Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort (Q30843946)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

0 references

Laura Ambra Nicolini

2

object named as

Laura Ambra Nicolini

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Alessandro Cozzi-Lepri

6

object named as

Alessandro Cozzi-Lepri

0 references

Antonella d'Arminio Monforte

12

object named as

Antonella d'Arminio Monforte

0 references

Antonio Di Biagio

object named as

Antonio Di Biagio

1

0 references

Massimo Andreoni

object named as

Massimo Andreoni

10

0 references

Andrea Antinori

5

object named as

Andrea Antinori

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

7

object named as

Andrea Gori

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Cristina Mussini

9

object named as

Cristina Mussini

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Patrizia Lorenzini

3

object named as

Patrizia Lorenzini

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

4

object named as

Massimo Puoti

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Jacopo Vecchiet

8

object named as

Jacopo Vecchiet

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Claudio Viscoli

11

object named as

Claudio Viscoli

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

author name string

For The Icona Foundation Study Group

13

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

publication date

1 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

151-160

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Hepatotoxicity of antiretrovirals: incidence, mechanisms and management

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation.

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Risk and determinants of developing severe liver toxicity during therapy with nevirapine-and efavirenz-containing regimens in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Pitfalls of assessing hepatotoxicity in trials and observational cohorts

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Virologic response to tipranavir-ritonavir or darunavir-ritonavir based regimens in antiretroviral therapy experienced HIV-1 patients: a meta-analysis and meta-regression of randomized controlled clinical trials

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96.

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Liver enzymes elevation after HAART in HIV-HCV co-infection

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999.

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Drug-induced liver injury associated with HIV medications

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE st

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Hepatic safety profile of fosamprenavir-containing regimens in HIV-1-infected patients with or without hepatitis B or C coinfection

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Hepatic profile analyses of tipranavir in Phase II and III clinical trials

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Safety, Tolerability, and Efficacy of Darunavir (TMC114) with Low-Dose Ritonavir in Treatment-Experienced, Hepatitis B or C Co-infected Patients in POWER 1 and 3

1 reference

https://api.crossref.org/works/10.1310/HCT1504-151

21 January 2018

Identifiers

10.1310/HCT1504-151

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30843946&oldid=1742021116"